CHARLOTTE ARDOIN: Open Payments
NPI 1841857778 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,064 in 42 payments from 17 companies in 2025. Trend: 2023 $867 · 2024 $812 · 2025 $1,064
Food & beverage: $1,064
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 8 | $260 |
| AstraZeneca Pharmaceuticals LP | 11 | $217 |
| Abbott Laboratories | 1 | $118 |
| Exact Sciences Corporation | 3 | $74 |
| Vanda Pharmaceuticals Inc. | 3 | $56 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| ABBVIE INC. | 2 | $48 |
| Dexcom, Inc. | 1 | $34 |
| Corium, LLC | 2 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $30 |
Products named: Auvelity, CARDIOMEMS, FARXIGA, AIRSUPRA, FANAPT, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, Dexcom G6 Transmitter.
Industry payments across LA — which companies pay providers there.
